ARTICLE | Clinical News
Colobreathe colistimethate sodium regulatory update
March 5, 2012 8:00 AM UTC
The European Commission approved Colobreathe colistimethate sodium to treat chronic lung infection caused by Pseudomonas aeruginosa in cystic fibrosis (CF) patients ages >=6 years. The inhaled dry pow...